Zacks Research Issues Positive Outlook for IDEX Earnings

IDEX Corporation (NYSE:IEX) – Equities research analysts at Zacks Research increased their Q3 2026 earnings per share estimates for IDEX in a research note issued to investors on Wednesday, August 19th. Zacks Research analyst Team now forecasts that the industrial products company will earn $2.20 per share for the quarter, up from their prior estimate of $2.17. The consensus estimate for IDEX’s current full-year earnings is $8.84 per share. Zacks Research also issued estimates for IDEX’s FY2026 earnings at $8.70 EPS, Q1 2027 earnings at $2.11 EPS, Q2 2027 earnings at $2.33 EPS, Q3 2027 earnings at $2.38 EPS, Q4 2027 earnings at $2.38 EPS, FY2027 earnings at $9.21 EPS and FY2028 earnings at $10.45 EPS.

IDEX (NYSE:IEX) last issued its earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The firm had revenue of $920.60 million for the quarter, compared to analyst estimates of $905.38 million. During the same quarter in the prior year, the firm earned $2.07 earnings per share. IDEX’s revenue for the quarter was up 6.4% on a year-over-year basis. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS.

IEX has been the subject of several other reports. DA Davidson lifted their price target on IDEX from $230.00 to $240.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Robert W. Baird set a $257.00 price target on shares of IDEX in a research note on Thursday, April 30th. TD Cowen raised their price objective on IDEX from $260.00 to $275.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Argus boosted their target price on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Finally, Stifel Nicolaus upped their price objective on shares of IDEX from $257.00 to $268.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Eight investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $260.80.

IDEX Price Performance

NYSE:IEX opened at $234.34 on Thursday. The firm’s fifty day moving average is $227.22 and its two-hundred day moving average is $212.47. The firm has a market cap of $17.28 billion, a price-to-earnings ratio of 33.72, a PEG ratio of 2.21 and a beta of 0.98. IDEX has a one year low of $158.19 and a one year high of $243.80. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.15 and a current ratio of 3.05.

IDEX Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were paid a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend was Monday, July 6th. IDEX’s dividend payout ratio is presently 42.01%.

Insider Buying and Selling at IDEX

In other news, CAO Lisa M. Anderson sold 385 shares of the company’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the sale, the chief accounting officer owned 4,327 shares of the company’s stock, valued at approximately $1,032,378.93. This represents a 8.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.50% of the company’s stock.

Institutional Trading of IDEX

Large investors have recently made changes to their positions in the company. Empowered Funds LLC increased its position in shares of IDEX by 3.4% in the 1st quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company’s stock valued at $298,000 after purchasing an additional 54 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in IDEX by 4.0% during the first quarter. EverSource Wealth Advisors LLC now owns 1,446 shares of the industrial products company’s stock worth $274,000 after buying an additional 56 shares during the period. Evolve Private Wealth LLC raised its position in IDEX by 2.8% in the 1st quarter. Evolve Private Wealth LLC now owns 2,125 shares of the industrial products company’s stock valued at $403,000 after purchasing an additional 58 shares during the last quarter. Sanctuary Advisors LLC raised its holdings in shares of IDEX by 2.6% in the first quarter. Sanctuary Advisors LLC now owns 2,443 shares of the industrial products company’s stock valued at $463,000 after buying an additional 62 shares during the last quarter. Finally, Mackenzie Financial Corp raised its stake in IDEX by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 2,562 shares of the industrial products company’s stock valued at $458,000 after acquiring an additional 70 shares during the last quarter. 97.96% of the stock is currently owned by hedge funds and other institutional investors.

Key IDEX News

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks Research increased its Q3 2026 EPS estimate to $2.20 from $2.17 and lifted its FY2026 forecast to $8.70 from $8.46. The firm also raised estimates for Q1 2027, Q3 2027, Q4 2027, FY2027 and FY2028, with FY2028 EPS increasing to $10.45 from $10.27. The broad-based upward revisions are likely supporting investor sentiment toward IDEX (IEX).
• Positive Sentiment: Zacks upgraded IDEX to a No. 2 (Buy) ranking, citing growing optimism about the company’s earnings prospects. The upgrade provides additional fundamental support for the stock. Idex Upgraded to Buy: Here’s Why
• Neutral Sentiment: A report highlighted a board shift at IDEX and said the change puts the company’s valuation back in focus. With IEX trading near its 52-week high and at a relatively elevated earnings multiple, valuation could become a more important factor for investors. IDEX Board Shift Puts Valuation Back in Focus
• Negative Sentiment: Zacks lowered its Q2 2027 EPS estimate to $2.33 from $2.43. However, the isolated reduction is outweighed by the increases to most other quarterly and annual forecasts.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.